July 7, 2026- Cepheid announced the publication of a study demonstrating the real-world impact of the Xpert Xpress MVP (multiplex vaginal panel) test when used at the point of care. The study showed that significantly more women with vaginitis symptoms (e.g., abnormal discharge, odor, itching, or discomfort) received appropriate treatment within 24 hours of their clinic visit when tested with Xpert Xpress MVP compared to standard diagnostic methods. Standard methods are still common in clinical practice and include symptom-based assessment and microscopy.